RSV

Latest News

Nursing home care | Image credit: Kzenon - stock.adobe.com
Low RSV Vaccination Rates in Nursing Homes Highlight Urgent Need for Uptake

November 24th 2024

Significant gaps in vaccination coverage among nursing home residents leaves vulnerable populations at risk for severe complications, report finds.

Air purifier | Image credit: Prathankarnpap - stock.adobe.com
In-Room Air Purifiers Could Impact RSV Incidence Among Older Adults

November 22nd 2024

RSV risk survey | Image credit: Richelle - stock.adobe.com
Community Pharmacies Hold Key Role in Protecting Older Adults From RSV

November 20th 2024

Blood sample tube for RSV test. | Image credit: JUN LI - stock.adobe.com
RSV Vaccine Proven Effective in Reducing RSV-Related Hospitalizations

November 15th 2024

RSV, COVID, Flu vaccines. | Image credit: angellodeco - stock.adobe.com
Impact of RSV on Hospitalizations in US Adults Prior to Vaccine Introduction

November 14th 2024

More News

Lungs
July 28th 2023

Adults Follow Biannual Pattern of RSV Infection

Julia Bonavitacola
A study that analyzed pre- and postpandemic respiratory syncytial virus (RSV) seasons found that children and adults followed the same biannual pattern.
Lungs
July 25th 2023

RSV Detection in Infants Associated With Temperature, Level of Medical Care

Julia Bonavitacola
A study conducted in Colombia found that detection of respiratory syncytial virus (RSV) was associated with air pollutants, the health care system, and weather.
Lungs
July 20th 2023

RSV Infection Is Seasonal, Age-Dependent, According to 10-Year Study in China

Julia Bonavitacola
A study conducted in China found that respiratory syncytial virus (RSV) epidemic was seasonal and most often infected infants born 1 to 2 months before the start of the season.
fda approved, text on paper on white background near glasses and magnifying glass: © Svetlana - stock.adobe.com
July 17th 2023

FDA Approves Beyfortus for Use in Infants With RSV

Julia Bonavitacola
Beyfortus, which can help prevent respiratory syncytial virus (RSV) in infants and toddlers, was approved by the FDA on July 17.
Vaccine
July 13th 2023

Influenza Vaccination Could Reduce Hospitalization for RSV

Julia Bonavitacola
A study from Western Australia found that the influenza vaccine has a possible protective effect against hospitalization for respiratory syncytial virus (RSV).
Baby
July 11th 2023

Study Finds Mortality, Hospitalizations Due to RSV Highest in Infants, Older Adults

Julia Bonavitacola
Older adults and infants were found to have the highest mortality and hospitalization rates of respiratory syncytial virus (RSV).
Young boy at doctor's
July 5th 2023

C-Reactive Protein May Hold Promise as RSV Marker

Julia Bonavitacola
In a recent study, immune-inflammatory index, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio were associated with infection of respiratory syncytial virus (RSV) in children.
Lungs
June 27th 2023

Vulnerable Populations Demonstrated Similar Burden of Illness for RSV and Influenza

Julia Bonavitacola
Residents of homeless shelters were tested for respiratory syncytial virus (RSV) and influenza, which were found to have similar prevalence in the population.
Baby
June 22nd 2023

Nearly One-Third of Infant Acute Hospitalizations in 4 Countries Associated With RSV

Julia Bonavitacola
Hospitalizations of infants in 4 middle-income countries were associated with respiratory syncytial virus (RSV) during the respiratory illness season.
Woman coughing
June 19th 2023

Cases of RSV in Older Adults Likely Underestimated in Studies

Julia Bonavitacola
The burden of respiratory syncytial virus (RSV) and the effect of vaccines could be affected by underestimation of RSV in older adults.
Boy with doctor
June 16th 2023

RT-PCR Most Sensitive Pediatric Diagnostic Test for RSV

Julia Bonavitacola
Respiratory syncytial virus (RSV) was detected easiest when using reverse transcription polymerase chain reaction (RT-PCR) tests in a pediatric population.
Person receiving vaccine
June 12th 2023

FDA Advisory Committee Recommends Nirsevimab Vaccination for RSV in Infants

Julia Bonavitacola
Nirsevimab was unanimously recommended by the FDA Advisory Committee for immunization against respiratory syncytial virus (RSV) in infants.
nurse holding and reading binder
June 7th 2023

Study Validates RiiQ Symptoms Scale for Assessing RSV Symptoms, Severity

Hayden E. Klein
The Respiratory Infection Intensity and Impact Questionnaire (RiiQ) Symptoms Scale demonstrated logical patterns of upper and lower respiratory symptoms among participants.
Baby
June 5th 2023

Cost of RSV Hospitalization Could Decrease if Treatment Targets Children Younger Than 3 Months

Julia Bonavitacola
The sharp reduction in costs for hospitalization from respiratory syncytial virus (RSV) in infants 3 months and younger after the COVID-19 pandemic outweighed the cost increase for children aged 3 to 24 months.
Baby
June 1st 2023

Oxygen Support, Hospitalization More Frequent in Children With RSV

Julia Bonavitacola
Children were hospitalized most commonly due to respiratory syncytial virus (RSV) compared with influenza and COVID-19 during a season with respiratory pathogen cocirculation.
Money
May 25th 2023

RSV Infection Imparts Substantial Economic Burden in All Age Groups

Julia Bonavitacola
Although lack of routine testing and limitations to current diagnostic testing likely lead to underreporting of respiratory syncytial virus, RSV still poses a substantial economic burden.
coffee and newspaper
May 18th 2023

What We’re Reading: Expanding Student Health Care; Depression Soars; RSV Vaccine for Infants

AJMC Staff
The Biden administration said it will expand health care access, including mental health care, to students; depression reaches an all-time high in the United States; the FDA’s independent vaccine advisers are meeting to discuss the safety and effectiveness of a respiratory syncytial virus (RSV) vaccine.
Child in hospital bed
May 15th 2023

RSV More Severe, Affected Older Children in Colorado During the Pandemic

Julia Bonavitacola
A recent study compared hospitalizations and ages of children with respiratory syncytial virus (RSV) infection before the pandemic and afterwards.
Lungs
May 14th 2023

RSV, Influenza Diagnosis Likely Predicted by Age

Julia Bonavitacola
An analysis of an urban population of children indicated that age was a strong predictor in the diagnosis of respiratory syncytial virus (RSV) and influenza.
Young boy with doctor
May 8th 2023

RSV Infection in Infancy Linked to Increased Risk of Childhood Asthma

Julia Bonavitacola
A study found that not being infected with respiratory syncytial virus (RSV) in the first year of life was associated with a decreased risk of developing asthma in childhood.
First Respiratory Syncytial Virus Vaccine Approved by FDA
May 3rd 2023

First Respiratory Syncytial Virus Vaccine Approved by FDA

Julia Bonavitacola
A vaccine for adults 60 years and older was approved by the FDA for protection against respiratory syncytial virus, making it the first such vaccine to be approved worldwide.
Lungs
May 3rd 2023

Nonpharmaceutical Interventions Affected Characteristics, Seasonality of RSV

Julia Bonavitacola
Further epidemiologic studies on nonpharmaceutical interventions are warranted to assess their relationship with respiratory syncytial virus (RSV).
Lungs
April 25th 2023

Nomogram Could Help Physicians Identify Severe RSV-Associated Bronchiolitis

Julia Bonavitacola
A nomogram that could assist physicians in predicting severe respiratory syncytial virus (RSV)–associated bronchiolitis early on was established and validated in a recent study.
Vaccine
April 25th 2023

MVA-BN-RSV Vaccine Effective in Lowering Viral Load, Reducing RSV Infections

Julia Bonavitacola
A new study found that the MVA-BN-RSV vaccine was able to lower symptom scores and resulted in fewer confirmed RSV infections vs placebo.
Child in hospital bed
April 20th 2023

Increased Risk of Complications Found in Patients With RSV

Julia Bonavitacola
Although the 28-day mortality for patients with respiratory failure did not differ between patients with and without respiratory syncytial virus (RSV), complications were more common in those with RSV.
Boy with doctor
April 13th 2023

Estimating Trends, Quantifying Changes From RSV's Burden on Health Care Systems

Julia Bonavitacola
Long-term temporal and spatial trends, as well as changes, can be estimated using hospital admission data when the burden on health care systems is increased.
Baby
April 10th 2023

Higher Rates of Respiratory Support Needed in Patients Admitted With RSV

Julia Bonavitacola
Patients who were admitted to the hospital for respiratory syncytial virus (RSV) had a higher risk of a complex hospital course and had higher rates of respiratory support compared with patients admitted for influenza.
Woman in hospital
April 5th 2023

Study Explores Mortality Rates and Risk Factors in Patients Hospitalized for RSV

Julia Bonavitacola
A recent study found the mortality rate for patients hospitalized for respiratory syncytial virus (RSV) to be 6.6%, with approximately 25% of hospitalized patients requiring admission to the intensive care unit.
Lungs
April 5th 2023

RSV Infections More Frequent, Severe in Older Adults

Julia Bonavitacola
A new study has found that respiratory syncytial virus (RSV) infections were more frequent and severe compared with influenza A/B in older adults.
What We’re Reading: Health Insurers to Cut Prior Authorization; Bipartisan Bill Aims to Stop MA Overpayments; J&J Backs Out of World’s First RSV Vaccine Race
March 30th 2023

What We’re Reading: Health Insurers to Cut PA Process; Bipartisan Bill to Stop MA Overpayments; J&J Ends RSV Vaccine Work

AJMC Staff
Payers are looking to roll back on paperwork requirements for prior authorization (PA); CMS and Medicare Advantage (MA) insurers battle over new regulations; Johnson & Johnson (J&J) falls behind Pfizer and GSK for vaccine approval.
<123>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo